Mobile app for stroke clinicians and emergency medical personnel to predict the risk of long-term adverse outcome in ischemic stroke patients after anti-thrombolytic therapy using recombinant tissue plasminogen activator (rt-PA). Based on a new calculation method developed at the Yale School of Medicine (manuscript under review).